BusinessInnovest Global Inc. Signs Letter of Intent to Acquire 20% of StemVax Therapeutics, a Biotechnology & Health Sciences CompanyBy Nasdaq OMXMar 19, 2018, 12:01 PM UTC
BusinessCesca Therapeutics to Announce Financial Results for the Transition Period From July 1, 2017 to December 31, 2017 on March 22By Nasdaq OMXMar 15, 2018, 11:01 AM UTC
BusinessImmune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Follicular LymphomaBy Nasdaq OMXMar 12, 2018, 12:01 PM UTC
BusinessAtara Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care ConferenceBy Nasdaq OMXMar 6, 2018, 9:06 PM UTC
BusinessTodos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screeningBy Nasdaq OMXMar 5, 2018, 1:02 PM UTC
BusinessCidara Announces Appointment of Chrysa Mineo as Independent DirectorBy Nasdaq OMXMar 1, 2018, 9:05 PM UTC
